CIK 0000200406
- Large accelerated filer
JOHNSON & JOHNSON
Sign in to watch- Ticker
- JNJ
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Jan 3
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 221024240
- Phone
- +1 732-524-2455
- Business address
- ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, 08933
- Former names
- JOHNSON & JOHNSON ET AL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,947,986
- in 2 filings
Net −$12,947,986. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-19 | Fasolo Peter Exec VP, Chief HR Officer | Sale | −100 | $164.50 | $16K | 183,224.01 |
| 2022-10-19 | Fasolo Peter Exec VP, Chief HR Officer | Sale | −100 | $164.50 | $16K | 183,124.01 |
| 2022-10-19 | Fasolo Peter Exec VP, Chief HR Officer | Sale | −100 | $164.50 | $16K | 183,024.01 |
| 2022-10-19 | Fasolo Peter Exec VP, Chief HR Officer | Sale | −127 | $164.50 | $21K | 182,897.01 |
| 2022-10-19 | Fasolo Peter Exec VP, Chief HR Officer | Sale | −128 | $164.50 | $21K | 182,769.01 |
| 2022-10-19 | Fasolo Peter Exec VP, Chief HR Officer | Sale | −190 | $164.50 | $31K | 182,579.01 |
| 2022-10-19 | Fasolo Peter Exec VP, Chief HR Officer | Sale | −190 | $164.50 | $31K | 182,389.01 |
| 2022-10-19 | Fasolo Peter Exec VP, Chief HR Officer | Sale | −200 | $164.50 | $33K | 182,189.01 |
| 2022-10-19 | Fasolo Peter Exec VP, Chief HR Officer | Sale | −200 | $164.50 | $33K | 181,989.01 |
| 2022-10-19 | Fasolo Peter Exec VP, Chief HR Officer | Sale | −200 | $164.50 | $33K | 181,789.01 |
| 2022-10-19 | Fasolo Peter Exec VP, Chief HR Officer | Sale | −200 | $164.50 | $33K | 181,589.01 |
| 2022-10-19 | Fasolo Peter Exec VP, Chief HR Officer | Sale | −200 | $164.50 | $33K | 181,389.01 |
| 2022-10-19 | Fasolo Peter Exec VP, Chief HR Officer | Sale | −200 | $164.50 | $33K | 181,189.01 |
| 2022-10-19 | Fasolo Peter Exec VP, Chief HR Officer | Exercise or conversion · Employee Stock Options (Right to Buy) | −70,126 | 0 | ||
| 2022-09-06 | WEINBERGER MARK A Director | Grant or award · Deferred Share Units | +260.65 | $164.11 | $43K | 6,035.04 |
| 2022-09-06 | Washington A. Eugene Director | Grant or award · Deferred Share Units | +379.31 | $164.11 | $62K | 27,812.19 |
| 2022-09-06 | HEWSON MARILLYN A Director | Grant or award · Deferred Share Units | +260.05 | $164.11 | $43K | 5,912.02 |
| 2022-06-10 | Wengel Kathryn E EVP, Chief GSC Officer | Exercise or conversion | +40,000 | $72.54 | $2.9M | 111,310.87 |
| 2022-06-10 | Wengel Kathryn E EVP, Chief GSC Officer | Sale | −100 | $173.00 | $17K | 111,210.87 |
| 2022-06-10 | Wengel Kathryn E EVP, Chief GSC Officer | Sale | −174 | $173.00 | $30K | 111,036.87 |
Page 55 of 60 · 1,189 trades